What opportunities do I have for earning American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points with the New England Journal of Medicine (NEJM)? Currently ...

We strive to produce fellows who are confident in their practice and well-prepared for ABIM: Hematology and Oncology board certification. We aspire to cultivate a culture of well-being, collegiality, ...

The American Board of Internal Medicine (ABIM) has revoked the board certification of two physicians involved in the Front ...

The American Board of Internal Medicine (ABIM) has created a training pathway for residents committed to academic physician-scientist careers. The ABIM Research Pathway (also known as a “short track”) ...

NYU Grossman School of Medicine's Oncology Two-Week Elective introduces students to the field of Medical Oncology ...

Opinions expressed by Forbes Contributors are their own. I am the Kester and Brynes Professor at Columbia Business School and a Chazen Senior Scholar at the Jerome A. Chazen Institute for Global ...

The World Bank Group Sanctions Board, composed of seven (7) external judges, is an independent administrative tribunal that serves as the final decision-maker in all contested cases of sanctionable ...

WALTHAM, Mass - Mural Oncology plc (NASDAQ:MURA), a company specializing in engineered cytokine therapies for cancer treatment, has announced the addition of Sachiyo Minegishi to its board of ...

Dr Aldea is board certified in medical oncology.Dr Aldea conducts collaborative clinical and translational investigations as part of a robust precision medicine multi-disciplinary group.

Dr. Vasconcelles is an accomplished biopharmaceutical executive with more than 25 years of oncology drug development experience and industry leadership. “On behalf of our Board and leadership ...

WALTHAM, Mass - Mural Oncology plc (NASDAQ:MURA), a company specializing in engineered cytokine therapies for cancer treatment, has announced the addition of Sachiyo Minegishi to its board of ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Shalini Sharp to its Board of Directors and as a member of the Board’s Audit Committee ...